ConductScience.org, home

Paper9533769

Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system.

Fulda S and 3 others. Int J Cancer, 1998. Cited by 150 papers, by iCite.

Cite this record

ConductScience Library. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system. Papers, record 9533769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9533769

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system.
PubMed
Journal
Int J Cancer
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
150
iCite
Relative citation ratio, by iCite
2.77
iCite
Revised in PubMed
2019-07-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fulda SS
2Los MM
3Friesen CC
4Debatin KMK M

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
fas ReceptorMajor topic
ATP Binding Cassette Transporter, Subfamily B, Member 1
Cysteine Endopeptidases
Dose-Response Relationship, Drug
Fluorescence
Humans
Time Factors
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.

PMIDTitleJournalYearIn PapersSource
40868135Mechanism of RCD and the Role of Different Death Signaling Pathways in Cancer.Biomedicines2025https://conductscience.org/library/papers/40868135PubMed
40678726Potential value and cardiovascular risks of programmed cell death in cancer treatment.Front Pharmacol2025https://conductscience.org/library/papers/40678726PubMed
39319154Synthesis and in vitro evaluation of cross-linked tragacanthin nanofibers as implants for delivery of cisplatin to hepatocellular carcinoma.Heliyon2024https://conductscience.org/library/papers/39319154PubMed
38264532Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors.Front Pharmacol2023https://conductscience.org/library/papers/38264532PubMed
35165859Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.Exp Suppl2022https://conductscience.org/library/papers/35165859PubMed
31652776Destined to Die: Apoptosis and Pediatric Cancers.Cancers (Basel)2019https://conductscience.org/library/papers/31652776PubMed
28177892Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis.Oncotarget2017https://conductscience.org/library/papers/28177892PubMed
26327844Mitochondrial dysfunction in cancer.Prz Menopauzalny2014https://conductscience.org/library/papers/26327844PubMed
25246270Human-gyrovirus-Apoptin triggers mitochondrial death pathway--Nur77 is required for apoptosis triggering.Neoplasia2014https://conductscience.org/library/papers/25246270PubMed
24648686Combined treatment of murine fibrosarcoma with chemotherapy (Paclitaxel), radiotherapy, and intratumoral injection of dendritic cells.Ann Dermatol2014https://conductscience.org/library/papers/24648686PubMed
24128051Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.Immunology2014https://conductscience.org/library/papers/24128051PubMed
23817665β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK.Int J Oncol2013https://conductscience.org/library/papers/23817665PubMed
23441073Regulation of cell death in cancer-possible implications for immunotherapy.Front Oncol2013https://conductscience.org/library/papers/23441073PubMed
23165211Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent.Cell Cycle2012https://conductscience.org/library/papers/23165211PubMed
21943236Apoptosis in cancer: from pathogenesis to treatment.J Exp Clin Cancer Res2011https://conductscience.org/library/papers/21943236PubMed
21509038Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway.Cell Death Dis2011https://conductscience.org/library/papers/21509038PubMed
20182539Evasion of apoptosis as a cellular stress response in cancer.Int J Cell Biol2010https://conductscience.org/library/papers/20182539PubMed
20182529Cellular stress responses: cell survival and cell death.Int J Cell Biol2010https://conductscience.org/library/papers/20182529PubMed
20013802Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.Int J Cancer2010https://conductscience.org/library/papers/20013802PubMed
19381670A cDNA microarray analysis identifies 52 genes associated with cis-diamminedichloroplatinum susceptibility in head and neck squamous cell carcinoma cell lines.Eur Arch Otorhinolaryngol2010https://conductscience.org/library/papers/19381670PubMed

See all 44 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
CASP1834PubTator's text mininghttps://conductscience.org/library/genes/834NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
FASLG356PubTator's text mininghttps://conductscience.org/library/genes/356NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9533769

GET https://conductscience.org/api/papers/v1/9533769/cited_by?page=2